Correlation between asymmetric dimethylarginine maternal plasma levels and preeclampsia

Clinical and Experimental Obstetrics and Gynecology

Volumn 38, Issue 2, 2011, Pages 134-136

  Savvidis, A ^a   Daniilidis, A ^a   Giannoulis, C ^a   Tantanasis, T ^a   Koiou, K ^a   Zournatzi, V ^a   Tzafettas, J ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

ADMA; Preeclampsia; Pregnancy

Indexed keywords

N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE SYNTHASE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL BLOOD; PREECLAMPSIA; PREGNANT WOMAN;

ARGININE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 79960246381     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. ACOG practice bulletin. "Diagnosis and management of preeclampsia and eclampsia: Number 33, January 2002". Obstet. Gynecol., 2002, 99, 159.
2. Contreras F., Fouilloux C., Bolivar A., Betancourt M.C., Colmenares Y., Rivero M. et al.: "Endothelium and hypertensive disorders in pregnancy". Am. J. Ther., 2003, 10, 415.
3. King R.G., Di Iulio J.L., Gude N.M., Brennecke S.P.: "Effect of asymmetric dimethyl arginine on nitric oxide synthase activity in normal and pre-eclamptic placentae". Reprod. Fertil. Dev., 1995, 7, 1581.
4. Rytlewski K., Olszanecki R., Korbut R., Zdebski Z.: "Effects of prolonged oral supplementation with L-arginine on blood pressure and nitric oxide synthesis in preeclampsia". Eur. J. Clin. Invest., 2005, 35, 32.
5. Staff A.C., Berge L., Haugen G., Lorentzen B., Mikkelsen B., Henriksen T.: "Dietary supplementation with L-arginine or placebo in women with preeclampsia". Acta Obstet. Gynecol. Scand., 2004, 83, 103.
6. Wang Y., Gu Y., Zhang Y., Lewis D.F.: "Evidence of endothelial dysfunction in preeclampsia. Decreased endothelial nitric oxide synthase expression is associated with increased cell permeability in endothelial cells from preeclampsia". Am. J. Obstet. Gynecol., 2004, 190, 817.
7. Altun Z.S., Uysal S., Guner G., Yilmaz O., Posaci C.: "Effects of oral L-arginine supplementation on blood pressure and asymmetric dimethylarginine in stress-induced preeclamptic rats". Cell. Biochem. Fund., 2008, 26, 648.
8. Fickling S.A., Williams D., Vallance P., Nussey S.S., Whitley G.S.T.J.: "Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and preeclampsia". Lancet, 1993, 342, 242.
9. Petterson A., Hedner T., Milsom I.: "Increased circulating concentrations of ADMA, an endogenous inhibitor of nitric oxide synthesis in preeclampsia". Acta Obstet. Gynecol. Scand., 1998, 77, 808.
10. Savidou M., Hingorani A., Tsikas D., Frolich J., Vallance P, Nicolaides K.: "Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop preeclampsia". Lancet, 2003, 361, 1511.
11. Ellis J., Wennerholm U.B., Bengtsson A., Liglia H., Petterson A., Sultan B. et al.: "Levels of dimethylarginines and cytokines in mild and severe preeclampsia". Acta Obstet. Gynecol. Scand., 2001, 80, 602.
12. Slaghekke F., Dekker G., Jeffries B.: "Endogenous inhibitors of nitric oxide and preeclampsia. A review". J. Mater.-Fet. Neon. Med., 2006, 19, 447.
13. Verhoeven M.O., Hemelaar M., van der Mooren M.J., Kenemans P., Teerlink T.: "Oral, more than transdermal, estrogen therapy lowers asymmetric dimethylarginine in healthy postmenopausal women. A randomized, placebo controlled study". J. Intern. Med., 2006, 259, 199.
14. Sibai B., Dekker G., Kupferminc M.: "Preeclampsia". Lancet, 2005, 565, 785.